Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-20

Clinical Trial Update: Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing clozapine to treatment as usual in people with intellectual disability and treatment-resistant psychosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Psychosis, Intellectual Disability | Phase 2 | Status: UNKNOWN